相关实验视频
Updated: Jul 10, 2025

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
糖尿病前期患者在初级甲状腺功能增强的手术后改善胰岛素耐药性
Claire Nomine-Criqui1, Florence Bihain1, Phi-Linh Nguyen-Thi2
1University of Lorraine, CHU Nancy - Hospital Brabois Adultes, Department of Surgery (CVMC), Unit of Endocrine and Metabolic Surgery (7ème étage), Nancy, France; University of Lorraine, INSERM NGERE / U1256, "Nutrition, Genetics, Environmental Risks," Faculty of Medicine, Nancy, France.
副甲状腺切除术显著降低了原发性副甲状腺功能障碍症患者的胰岛素耐药性,特别是那些糖尿病前期患者. 这种手术改善了葡萄糖代谢,突出了其治疗潜力.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 外科手术的结果
背景情况:
- 初级甲状腺功能障碍症与代谢异常有关.
- 副甲状腺切除术对胰岛素耐药性的影响需要进一步研究.
- 手术前的葡萄糖代谢状态可能会影响手术后的结果.
研究的目的:
- 为了评估胰岛素耐药性的变化12个月后副甲状腺切除术.
- 评估手术前葡萄糖代谢严重程度对这些变化的影响.
主要方法:
- 对231名接受副甲状腺切除术的患者进行观察性研究 (2016-2021年).
- 糖尿病前期定义为饥饿时的葡萄糖≥1.00g/L.
- 胰岛素耐药性通过胰岛素耐药性 (HOMA-IR) 的同居模式评估定义的胰岛素耐药性>2.5.5.
主要成果:
- 在手术前,32%的患者患有糖尿病前期,47%的患者患有胰岛素抵抗.
- 副甲状腺切除术后,HOMA-IR在糖尿病前期和胰岛素耐药性组 (P<.001) 都显著下降 (P<.001).
- 手术前的糖尿病和较高的HOMA-IR是减少胰岛素抵抗的独立预测因素.
结论:
- 副甲状腺切除术有效地降低了原发性副甲状腺症患者的胰岛素耐药性.
- 患有糖尿病前期或较高的手术前胰岛素抵抗症的患者受益最多.
- 对糖尿病前期的手术前查可以帮助选择外科候选人.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon

